药物诱导骨质疏松症的研究进展
Wenbin Tan1,2, Ting He1,2, Jia Li3,4,5
1The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
概括
药物诱导性骨质疏松症 (DIO) 是二次骨质疏松症的一个关键类型. 虽然治疗可以改善骨密度,但长期使用抗骨质疏松症药物需要仔细评估好处与风险,以预防不良事件.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 药物诱导骨质疏松症 (DIO) 是二次骨质疏松症的一个重要组成部分.
- 了解药物对骨健康的影响对于患者管理至关重要.
研究的目的:
- 审查常见药物对骨代谢的影响.
- 阐明药物诱导骨质疏松症背后的机制.
- 讨论DIO的潜在治疗策略.
主要方法:
- 对影响骨代谢的常见药物的文献综述.
- 对DIO提出的机制的分析.
- 评估当前和潜在的治疗干预措施.
主要成果:
- 某些药物可能会对骨代谢产生负面影响,导致DIO.
- 抗骨质疏松症药物可以改善骨矿物质密度并降低骨折风险.
- 长期使用抗骨质疏松症疗法可能会带来风险,包括非典型的股骨骨折.
结论:
- 个性化治疗计划对于管理DIO至关重要.
- 平衡药物的益处和不良影响对于预防和治疗DIO至关重要.
关键词:
这是一种5α减小酶抑制剂.抗抑郁药物是一种抗抑郁药物.抗瘤药物 抗瘤药物 抗瘤药物葡萄糖皮质类药物是什么利沃甲氧氨酸 (Levothyroxine) 是一种药物.在阿片类药物中,阿片类药物质子抑制剂的使用二次性骨质疏松症是什么更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
12.2K
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.8K
相关概念视频
Osteoclasts in Bone Remodeling
4.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Bone Disorders
6.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.0K
Bone Remodeling
40.9K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.9K
Hormones and Bone Tissue
4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
